title: Angiogenesis in cutaneous disease: part I.
abstract: Angiogenesis is an important process in normal physiology and disease pathogenesis. Angiogenesis is controlled in a healthy body by a system of angiogenic growth factors and angiogenesis inhibitors. When angiogenic growth factors are predominantly expressed, blood vessel growth occurs and disease may result. Successful therapies have been developed that target growth factors, their receptors, or the cascade pathways that are activated by growth factor/receptor interactions. There is good evidence that angiogenesis plays an important role in a wide range of cutaneous maladies, and angiogenesis-targeting therapies are playing an increasing role in the management of dermatologic disease. Cutaneous angiogenesis offers an exciting new arena for targeted dermatologic therapeutics.
  
  
  OBJECTIVE
  After completing this learning activity, participants should be able to distinguish angiogenic growth factors and inhibitors, recognize angiogenic mediating agents and compare their mechanisms of action, and apply the use of angiogenic mediating agents in clinical and research situations.
authors.affiliation: Department of Dermatology, University of California, Irvine, California 92612, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Nguyen
authors.forename: Van
authors.initials: V
authors.lastname: Hoang
authors.forename: Vivian
authors.initials: V
authors.lastname: Laquer
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Kelly
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000378:metabolism; D020533:Angiogenesis Inhibitors / Q000502:physiology / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D012871:Skin Diseases / Q000503:physiopathology*
chemical_list: D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors